← Open Payments lookup

JERRY KUNKEL: Open Payments

NPI 1548781164 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,794 in 104 payments from 17 companies in 2025. Trend: 2023 $1,449 · 2024 $4,530 · 2025 $5,794

Speaker / faculty: $3,700Food & beverage: $1,981Travel & lodging: $113
CompanyPaymentsAmount
ABBVIE INC.16$3,962
Vanda Pharmaceuticals Inc.23$482
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$401
Otsuka America Pharmaceutical, Inc.14$298
Neurocrine BioSciences, Inc.4$166
Axsome Therapeutics, Inc.4$78
Lundbeck LLC4$67
Teva Pharmaceuticals USA, Inc.4$67
Lilly USA, LLC3$48
Novo Nordisk Inc3$47

Products named: VRAYLAR, CAPLYTA, REXULTI, HETLIOZ, FANAPT, INGREZZA, Auvelity, AUSTEDO XR.

Industry payments across KY — which companies pay providers there.